Given its fundamental role in the mechanisms of translation, dysregulated activity of eIF3 is unsurprisingly associated with a wide array of human diseases, including a host of cancers [49,75–81], neurodegenerative diseases [82–84], and viral infections [48,74,85–87]. This evidence concerns the gene EIF3A and cancer.